Moderna’s unlikely journey to rivaling Big Pharma giants’ valuations

Boosted by the COVID vaccine, Moderna’s valuation has now leapfrogged that of well-established Big Pharma giants like Bristol Myers Squibb and Sanofi. Can it last? Read More

Leave a Reply

Your email address will not be published. Required fields are marked *